We're still accepting applications for fall 2024!
Apply Today
The next phase of coronavirus vaccine campaigns will require reaching Americans who have little access to the shots and those whose jobs make it difficult to take time off to get vaccinated, according to public health experts.
A recurring sentiment among some in the vaccine-hesitant community is a desire to wait to receive any of the three available COVID-19 vaccines until they have been officially approved by the Food and Drug Administration. And while the FDA has authorized the Pfizer, Moderna and Johnson & Johnson vaccines―and is expected to also approve each one in turn―for many people, the difference between “authorized” and “approved” has been confusing.
Fully vaccinated Americans can now safely shed their masks and skip social distancing, the U.S. Centers for Disease Control and Prevention said this week, sparking a flurry of questions about how the new guidelines will be implemented at businesses, schools and other places where fully vaccinated and unvaccinated people mingle.
Since the beginning of the pandemic, herd immunity has been portrayed as the holy grail to overcome the COVID-19 pandemic. Abram Wagner, research assistant professor of Epidemiology, explains why reaching herd immunity might not be as simple as we thought, and what vaccine hesitancy and availability have to do with it.
Soon, Michigan residents will be able to search the number of coronavirus cases, hospitalizations and deaths by race, ethnicity, age and gender as University of Michigan experts expand the capabilities of the statewide coronavirus MI Safe Start dashboard.
India has stepped up its coronavirus vaccination drive amid a deadly second wave of infections. The country on Sunday breached the 100,000 daily caseload mark for the first time since the pandemic began.